Gary A. Lyons, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,860 shares at $150.03 ($279K) on 2024-07-16, disclosed to the SEC on 2024-07-18.
Scheduled sale ($279k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.03 | 930 | $140K | 50.0% |
| 2 | $150.03 | 930 | $140K | 50.0% |
| Total | $150.03 avg | 1,860 | $279K | 100% |
| Filing → |
| NBIX | SELL | 2025-12-04 | $2.3M | — | Filing → |
| TVTX | SELL | 2024-10-04 | $1.2M | — | Filing → |
| NBIX | SELL | 2024-08-15 | $3.5M | — | Filing → |